TrialGynecologic oncology2015

Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an NRG oncology/gynecologic oncology group study (ADS-1236).

Linda R Duska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.